Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Clinical trial NCT07209189 · RECRUITING

Trial details

NCT number: NCT07209189
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Carcinoma Oral Cavity Cancer Oropharyngeal Cancer Laryngeal Cancer Sinonasal Squamous Cell Carcinoma HPV (Human Papillomavirus)-Associated Carcinoma Skull Base Tumors HPV 16 Positive Oropharyngeal Tumors (OPC)

Start date: 2026-02-18
Primary completion: 2030-10-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.